EAM
Eventide Asset Management’s Dianthus Therapeutics DNTH Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-1,000,000
| Closed | -$7.84M | – | 159 |
|
|
2020
Q4 | $7.84M | Sell |
1,000,000
-1,359,646
| -58% | -$10.7M | 0.12% | 113 |
|
|
2020
Q3 | $16M | Hold |
2,359,646
| – | – | 0.31% | 88 |
|
|
2020
Q2 | $17.7M | Buy |
2,359,646
+570,000
| +32% | +$4.28M | 0.39% | 72 |
|
|
2020
Q1 | $11.2M | Sell |
1,789,646
-1,604,248
| -47% | -$10.1M | 0.36% | 78 |
|
|
2019
Q4 | $51.5M | Buy |
3,393,894
+438,462
| +15% | +$6.65M | 1.45% | 23 |
|
|
2019
Q3 | $30.3M | Sell |
2,955,432
-539,807
| -15% | -$5.54M | 1% | 35 |
|
|
2019
Q2 | $50.8M | Buy |
3,495,239
+425,000
| +14% | +$6.18M | 1.54% | 19 |
|
|
2019
Q1 | $49.7M | Buy |
3,070,239
+419,431
| +16% | +$6.79M | 1.71% | 15 |
|
|
2018
Q4 | $14.8M | Buy |
2,650,808
+412,719
| +18% | +$2.31M | 0.66% | 54 |
|
|
2018
Q3 | $26.3M | Buy |
2,238,089
+1
| +0% | +$12 | 0.96% | 36 |
|
|
2018
Q2 | $29.5M | Buy |
+2,238,088
| New | +$29.5M | 1.22% | 34 |
|